Nilotinib Teva 150 mg tvrde kapsule
| Name | Nilotinib Teva 150 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-095777135 |
| Active Substance | nilotinibklorid dihidrat |
| Composition | jedna tvrda kapsula sadrži 150 mg nilotiniba (u obliku nilotinibklorid dihidrata) |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta Pharos Pharmaceutical Oriented Services Ltd., Metamorfossi Attikis, Grčka |
| Marketing Authorisation Holder | Teva GmbH, Graf-Arco-Strasse 3, Ulm, Njemačka |
| Marketing Authorisation Date | 18.06.2024 |
| MA Period of Validity | 18.06.2029 |
| Classification Number | UP/I-530-09/23-01/95 |
| Registration Number | 381-12-01/70-24-08 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EA03 |
| SmPC | download |
| PL | download |
